I-Know

I-Know is a knowledge discovery IT -based tool designed to aid early stroke diagnosis, stroke treatment, drug development and identification of risk factors as targets in disease prevention for the benefit of European industry and citizens.

Acute stroke is a major socioeconomic burden in EU. The disabilities following the disease develop rapidly and prompt treatment of patients is imperative. Currently a drug dissolving the blood clot (rtPA - thrombolysis) is the only established treatment, but this is only implemented at highly specialised centres. There is consequently a strong geographical inequality in the availability of this treatment - nationally and internationally within EU.

At the same time there is an intense search by pharmaceutical industry and academic biomedical research to identify drugs that will stop the tissue damage progressing after acute stroke.

The knowledge discovery tool, I-Know will:

  • Provide instant, user-friendly ITbased diagnosis and therapeutic guidance, reducing the infrastructural, economic and educational barriers currently hindering advanced stroke treatment at less specialised units.
  • Use advanced data mining techniques to model disease progression based on large multinational databases providing state-of-theart diagnosis of every EU citizen irrespective of knowledge barriers.
  • Provide a platform for modeling beneficial or adverse effects recorded during clinical trials, allowing optimal use of preclinical data in subsequent individualized patient management.
  • Be designed to integrate data across descriptive levels to devise disease models that will bring scientific progress to stroke research.

For further information, please visit:
http://www.cfin.au.dk

Project co-ordinator:
Dept. Neuroradiology, Aarhus Sygehus, Aarhus University Hospital, (DK)

Partners:

  • Institut National de la Santé et de Recherche Medicale (FR)
  • Université Claude Bernard (FR)
  • Fundació Privada Institut d'Investigació Biomédica de Girona (SP)
  • University of Cambridge (UK)
  • Universitätsklinikum Hamburg-Eppendorf (DE)
  • Universitätsklinikum Freiburg für die Medizinische Fakultät der Albert-Ludwigs-Universität (DE)
  • Systematic Software Engineering A/S (DK)
  • Dimac A/S (DK)

Timetable: from 05/06 – to 04/09

Total cost: € 3.876.347

EC funding: € 3.092.810

Instrument: STREP

Project Identifier: IST-2004-027294

Source: FP6 eHealth Portfolio of Projects

Most Popular Now

AI can Strengthen Pandemic Preparedness

How to identify the next dangerous virus before it spreads among people is the central question in a new Comment in The Lancet Infectious Diseases. In it, researchers discuss how...

'Future-Guided' AI Improves Se…

In the world around us, many things exist in the context of time: a bird’s path through the sky is understood as different positions over a period of time, and...

New AI Tool Scans Social Media for Hidde…

A new artificial intelligence tool can scan social media data to discover adverse events associated with consumer health products, according to a study published September 30th in the open-access journal...

Study Finds One-Year Change on CT Scans …

Researchers at National Jewish Health have shown that subtle increases in lung scarring, detected by an artificial intelligence-based tool on CT scans taken one year apart, are associated with disease...

New AI Tools Help Scientists Track How D…

Artificial intelligence (AI) can solve problems at remarkable speed, but it’s the people developing the algorithms who are truly driving discovery. At The University of Texas at Arlington, data scientists...

Yousif's Story with Sectra and The …

Embarking on healthcare technology career after leaving his home as a refugee during his teenage years, Yousif is passionate about making a difference. He reflects on an apprenticeship in which...

AI Tool Offers Deep Insight into the Imm…

Researchers explore the human immune system by looking at the active components, namely the various genes and cells involved. But there is a broad range of these, and observations necessarily...

New Antibiotic Targets IBD - and AI Pred…

Researchers at McMaster University and the Massachusetts Institute of Technology (MIT) have made two scientific breakthroughs at once: they not only discovered a brand-new antibiotic that targets inflammatory bowel diseases...

Highland to Help Companies Seize 'N…

Health tech growth partner Highland has today revealed its new identity - reflecting a sharper focus as it helps health tech companies to find market opportunities, convince target audiences, and...